By transiently and glucose-dependently stimulating insulin release, suppressing glucagon secretion, and delaying gastric emptying, GLP-1 RAs effectively reduce blood glucose levels in individuals with diabetes [4, 5]. This evidence concerns the gene GCG and diabetes mellitus.